Ajayi AF,Adebayo ET,Adebayo IO,Oyekunle OS,Amos VO,Bamidele SE,Olatinwo GO .2022 .Application of data science approaches to investigate autoimmune thyroid disease. Hypothyroidism: New Aspects of an Old Disease, : 23.
Alsahabi SA,Daghriri HH,Almutairi RA,Alrbaee AM,Khamees AF,Hubaysh LA,Alghamdi KA,Zughibi HM,Alssaygh AA,Makrami HA,Alshahrani MS .1947 .A review of laboratory advancements in thyroid stimulating receptor autoantibodies assays: Diagnostic and clinical applications. J. Int. Crisis Risk Commun. Res., 7(S9) : .
AL Majali S,Ebadi M,Ebadi Z,AG Z .2025 .Integrating nutrition and mental health: Mechanistic pathways, clinical evidence and public health policy implications. Wah Acad. J. Health Nutr, 1(2) : 33-40.
Azizi F,Amouzegar A,Khalili D,Abdi H,Tohidi M,Hedayati M,Cheraghi L,Mehrabi Y,Takyar M Y .2024 .Risk of recurrence at the time of withdrawal of short- or long-term methimazole therapy in patients with Graves' hyperthyroidism: a randomized trial and a riskscoring model. Endocrine, 84(2) : 577-88.
Bolakale-Rufai IK,Abioro I,Ngene SO,Woldeamanuel Y .2023 .Efficacy of methimazole before the administration of radioactive iodine in the management of Graves' disease: A systematic review and meta-analysis. Sao Paulo Med. , 141(5) : e2022225.
Chan FY,Ku YE,Lie WN,Chen HY .2025 .Webbased explainable machine learning-based drug surveillance for predicting sunitinib-and sorafenibassociated thyroid dysfunction: Model development and validation study. JMIR Form. Res., 9 : e67767.
Czarnywojtek A,Florek E,Pietronczyk K,Sawicka-Gutaj N,Ruchała M,Ronen O,Nixon IJ,Shaha AR,Rodrigo JP,Tufano RP,Zafereo M .2023 .The role of vitamin D in autoimmune thyroid diseases: a narrative review. J. Clin. Med, 12(4) : 1452.
Dwivedi SN,Kalaria T,Buch H T .2023 .Thyroid autoantibodies. J. Clin. Pathol, 76(1) : 19-28.
Ebadi AG .2025 .Synergistic approaches in diabetes management: The role of anti-diabetic drugs and herbal medicine in therapeutic strategies. Nepal J. Med. Sci., 10(2) : 68-81.
Ebadi AG,Selamoglu Z AG .2025 .Exploring the role of herbal medicines in modern pharmacology and drug development. Lat. Am. J. Pharm., 44(4) : 401-406.
Gallo D,Bruno A,Gallazzi M,Cattaneo SA,Veronesi G,Genoni A,Tanda ML,Bartalena L,Passi A,Piantanida E,Mortara L E .2023 .Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves' disease patients during methimazole treatment. Front. Endocrinol., 14 : 1145811.
Gu P,Pu B,Ma Y,Yue D,Xin Q,Li H,Liu T,Zheng X,Ouyang C .2023 .Appraising the causal relationship between thyroid function and rheumatoid arthritis: A two-sample bidirectional Mendelian randomization study. Front. Immunol., 14 : 1238757.
Han Z,Cen C,Ou Q,Pan Y,Zhang J,Huo D,Chen K D .2022 .The potential prebiotic berberine combined with methimazole improved the therapeutic effect of Graves' disease patients through regulating the intestinal microbiome. Front. Immunol., 12 : 826067.
Jiang Z,Li S,Yang L,Song X,Zhang X,Guo L,Guo J,Zhang H,Chen D H .2025 .Diagnostic value of serum TSI levels in Graves' disease and direct comparison of diagnostic performance with TRAb: A systematic review and meta-analysis. Clin. Biochem, 110989 : .
Kalra S,Selim S,Shrestha D,Somasundaram N,Raza SA,Baruah MP,Bhattacharya S,Gadve S,Bantwal G,Sahay R G .2024 .Best practices in the laboratory diagnosis, prognostication, prediction and monitoring of Graves' disease: role of TRAbs. , 24(1) : 274.
Bulow-Pedersen Karmisholt J andersen SL,Krejbjerg I,Nygaard A,Carle B,A B .2022 .Long-term methimazole therapy in Graves' hyperthyroidism and adverse reactions: A Danish multicenter study. Eur. Thyroid J., 11(3) : .
Ke C,Yu Y,Li J,Yu Y,Sun Y,Wang Y,Wang B,Lu Y,Tang M,Wang N,Chen Y .2025 .Genetic and plasma proteomic approaches to identify therapeutic targets for Graves' disease and Graves' ophthalmopathy. , : 87-98.
Khafaei M,Sadeghi Hajiabadi M and Abdolmaleki A .2021 .Role of 1,25-dihydroxycholecalciferol in immunological and molecular pathways involved in Multiple Sclerosis. Cent. Asian J. Med. Pharm. Sci. Innov, 1(2) : 55-66.
Kobayashi G,Okamura T,Hashimoto Y,Sakai K,Sumi M,Imai D,Kitagawa N,Hamaguchi M,Fukui M M .2025 .Pathogenesis of Graves' disease determined using single-cell sequencing with thyroid autoantigen peptide stimulation in B cells. Cells, 14(14) : 1102.
Kravchenko V,Zakharchenko T .2023 .Thyroid hormones and minerals in immunocorrection of disorders in autoimmune thyroid diseases. Front. Endocrinol., 14 : 1225494.
Lanzolla G,Marino M,Menconi F M .2024 .Graves' disease: Latest understanding of pathogenesis and treatment options. Nat. Rev. Endocrinol., 20(11) : 647-60.
Liu Q,Yang H,Chen Y,He X,Dong L,Zhang X,Yang Y,Tian M,Cheng W,Liu D,Yang G .2024 .Effect of thyroid peroxidase antibody titers trajectories during pregnancy and postpartum on postpartum thyroid dysfunction. Arch, 310(6) : 3229-38.
Ludgate ME,Masetti G,Soares P .2024 .The relationship between the gut microbiota and thyroid disorders. Nat. Rev. Endocrinol., 20(9) : 511-25.
Morshed S,Latif R,Davies TF .2023 .Signal responses to neutral TSH receptor antibody - A cycle of damage in the pathophysiology of Graves' disease. J. Autoimmun., 136 : 103012.
Ngan TT,Tra DH,Mai NT,Dung HV,Khai NV,Linh PV,Phuong NT .2025 .Developing a machine learningbased predictive model for levothyroxine dosage estimation in hypothyroid patients: A retrospective study. Front. Endocrinol., 16 : 1415206.
Othman RA .2023 .The frequency of thyroid stimulating blocking antibodies (TSBAbs) in individuals with newly diagnosed AITD. Cent. Asian J. Med. Nat. Sci., 4(5) : 38-44.
Ozdemir B,Khan A,Farooq Rashid R .2022 .The physiology of vitamin D and its involvement in cardiovascular diseases. Cent. Asian J. Med. Pharm. Sci. Innov, 2(4) : 128-140.
Pourzardosht N,Hashemi ZS,Mard-Soltani M,Jahangiri A,Rahbar MR,Zakeri A,Mirzajani E,Khalili S .2022 .Liothyronine could block the programmed death-ligand 1 (PDL1) activity: An e-pharmacophore modeling and virtual screening study. J. Recept. Signal Transduct, 42(1) : 34-42.
Rufino-Moya PJ,Zafra Leva R,Martinez-Moreno A,Buffoni L,Valderas Garcia E,Perez Arevalo J,MolinaHernandez V,Ruiz-Campillo MT,Herrera-Torres G,Martínez-Moreno FJ .2024 .Advancement in diagnosis, treatment and vaccines against Fasciola hepatica: A comprehensive review. Pathogens, 13(8) : 669.
Shang S,Xia J,He G,Zheng Y,Zhang J,Lu H,Wang H,Li W,Li Q,Chen X .2025 .Advances in precision medicine for lupus nephritis: Biomarker- and AI-driven diagnosis and treatment response prediction and targeted therapies. EBioMedicine, 117 : .
Sharma SD,Bluett J .2024 .Towards personalized medicine in rheumatoid arthritis. Open Access Rheumatol. Res. Rev., 89 : 114.
Silva AC,Damas II,Moma CA,Barreto IS,ZantutWittmann DE IS .2024 .Lower proportion of intrathyroidal B lymphocytes CD20+ associated to methimazole and lack of influence of iodide on lymphocyte subpopulations in Graves' disease. Mol. Cell, 592 : 112331.
Starosz A,Stożek K,Opęchowska A,Bossowski F,Moniuszko M,Grubczak K,Bossowski A .2024 .Effect of methimazole treatment on Th1, Th17 and Th22 lymphocytes in pediatric Graves' disease patients. Front. Immunol., 15 : 1431686.
Stasiak M,Stasiak B,Zawadzka-Starczewska K,Lewiński A .2023 .Significance of HLA in Graves' disease and Graves' orbitopathy in Asian and Caucasian populations - A systematic review. Front. Immunol., 14 : 1256922.
Takizawa H,Uchida T,Suzuki N,Onose H,Yamada E,Hashimoto K,Watanabe N,Nishida Y,Watada H Y .2025 .Influence of therapeutic inorganic iodine on long-term prognosis of Graves' disease: A multicenter prospective observational study. Endocr. J., 72(6) : 663-70.
Theiler-Schwetz V,Benninger T,Trummer C,Pilz S C .2022 .Mathematical modeling of free thyroxine concentrations during methimazole treatment for Graves' disease: Development and validation of a computer-aided thyroid treatment method. Front. Endocrinol., 13 : 841888.
Trzos S,Link-Lenczowski P,Sokołowski G,Pocheć E .2022 .Changes of IgG N-glycosylation in thyroid autoimmunity: the modulatory effect of methimazole in Graves' disease and the association with the severity of inflammation in Hashimoto's thyroiditis. Front. Immunol., 13 : 841710.
Vargas-Uricoechea H .2023 .Molecular mechanisms in autoimmune thyroid disease. Cells, 12(6) : 918.
Vargas-Uricoechea H,Nogueira JP,Pinzón-Fernández MV,Schwarzstein D MV .2023 .The usefulness of thyroid antibodies in the diagnostic approach to autoimmune thyroid disease. Antibodies, 12(3) : 48.
Wang Z,Bai J,Zou J,Yuan Y,Li S,Wang M .2024 .Association between thyroid autoimmunity and bone mineral density in patients with type 2 diabetes mellitus: a cross-sectional study. Endocrine, 85(2) : 604-14.
Wei M,Chu CQ M .2022 .Prediction of treatment response: Personalized medicine in the management of rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol, 36(1) : 101741.
Wu S,Yi J,Wu B .2024 .Casual associations of thyroid function with inflammatory bowel disease and the mediating role of cytokines. Front. Endocrinol., 15 : 1376139.
Xie P,Shen L,Peng R,Wang Y,Yin Q,Chen X,Jin Z,Ning G,Wang W,Wang S,Zhou Y .2025 .Effects of low-dose methotrexate with methimazole in patients with Graves' disease: Results of a randomized clinical trial. J. Clin. Endocrinol. Metab., 110(2) : 489-97.
Yang R,Li W,Niu Q,Yang W,Gu W,Wang X .2025 .Machine learning in lymphocyte and immune biomarker analysis for childhood thyroid diseases in China. , 25(1) : 249.
Yang Y,Chen H Y .2025 .Clinical application of thyrotropin receptor antibodies. Horm. Metab. Res., 57(2) : 79-87.
Yao P,Xie Y,Wang Y,Liang C,Huang B C .2024 .Comparison between thyroid stimulating immunoglobulin and TSH-receptor antibodies in the diagnosis and management of Graves' disease. Front. Endocrinol., 15 : 1487490.
Yao Z,Guo F,Tan Y,Zhang Y,Geng Y,Yang G,Wang S G .2024 .Causal relationship between inflammatory cytokines and autoimmune thyroid disease: A bidirectional two-sample Mendelian randomization analysis. Front. Immunol., 15 : 1334772.
Yu Y,Tong K,Deng J,Wu J,Yu R,Xiang Q .2025 .Unveiling the connection between micronutrients and autoimmune thyroiditis: Are they true friends? Biol. Trace Elem. , : 1-2.
Zhang C,Teng W,Wang C .2024 .The gut microbiota and its metabolites and their association with the risk of autoimmune thyroid disease: A Mendelian randomization study. Nutrients, 16(22) : 3898.
Zhang X,Zhao Q,Li B .2023 .Current and promising therapies based on the pathogenesis of Graves' ophthalmopathy. , 14 : 1217253.
Zheng H,Xu J,Chu Y,Jiang W,Yao W,Mo S,Song X,Zhou J .2022 .A global regulatory network for dysregulated gene expression and abnormal metabolic signaling in immune cells in the microenvironment of Graves' disease and Hashimoto's thyroiditis. Front. Immunol., 13 : 879824.
Zhuang DR,Hu X,Huang HB .2025 .Hub genes and key pathways of Graves' disease: Bioinformatics analysis and validation. Hormones, 24(3) : 605-619.